Clinical Trials Browser

Phase 3 × Completed × ibritumomab tiuxetan × Clear all

NCT02063685 2022-06-21

Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma

Phase 3 Completed

Lymphoma, Follicular

NCT00491491 2020-08-31

Zevalin-beam for Aggressive Lymphoma

Phase 3 Completed

60 enrolled 12 charts

Lymphoma, Non-Hodgkin